Cediranib (AZD2171, RECENTIN™) in Addition to Chemotherapy in Patients With Untreated Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Clinical Trials Related to Metastatic Colorectal Cancer
Related studies linked through entity extraction aliases.
Tailored Treatment in Metastatic Colorectal Cancer
- Status
- TERMINATED
- Phase
- PHASE3
Phase II Study of Bevacizumab, Capecitabine and Oxaliplatin in Colon Cancer
- Status
- COMPLETED
- Phase
- PHASE2
PRIME: Panitumumab Randomized Trial In Combination With Chemotherapy for Metastatic Colorectal Cancer to Determine Efficacy
- Status
- COMPLETED
- Phase
- PHASE3
1stline Study Capecitabine Administered on Continuous Way Plus Oxaliplatin&Bevacizumab Every 2weeks in Metastatic CCR.
- Status
- COMPLETED
- Phase
- PHASE2
Comparison of Treatment Effect of Chemotherapy With Panitumumab to Chemotherapy Alone
- Status
- COMPLETED
- Phase
- PHASE3
Phase III Randomized Study of 5-FU, CoFactor, and Avastin vs. 5-FU, LV and Avastin for First-Line Colorectal Cancer.
- Status
- UNKNOWN
- Phase
- PHASE3
Skin Toxicity Treatment in Metastatic Colorectal Cancer (mCRC) Patients Receiving Panitumumab + Irinotecan-based Therapy
- Status
- COMPLETED
- Phase
- PHASE2
Phase 2 Study of ABX-EGF (Panitumumab) in Japanese Subjects With M-colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
BAY 43-9006 Plus Cetuximab to Treat Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
IRIS Followed by mFOLFOX6 or the Reverse Sequence in Advanced Colorectal Cancer
- Status
- SUSPENDED
- Phase
- PHASE3
The MAX Study: Mitomycin C, Avastin and Xeloda in Patients With Untreated Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Safety and Efficacy of Folfox6 + Cetuximab Versus Folfiri +Cetuximab in Patients With Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Study of Glutamine as Prophylaxis for Irinotecan Induced Diarrhea
- Status
- COMPLETED
- Phase
- PHASE2
Cap/Iri Plus Cetuximab Compared to Cap/ox Plus Cetuximab in Patients With Metastatic Colorectal Cancer.
- Status
- COMPLETED
- Phase
- PHASE2
Cetuximab, Bevacizumab & 5FU/Leucovorin vs. Oxaliplatin, Bevacizumab & 5FU/Leucovorin in Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Irinotecan, 5-Fluorouracil and Leucovorin With or Without Iressa in the Treatment of Metastatic Colorectal Cancer
- Status
- WITHDRAWN
- Phase
- PHASE2
An Exploratory Pharmacogenomic Study of Monotherapy Erbitux in Subjects With Metastic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Oxaliplatin, 5-FU and Leucovorin in Combination With Oral Capecitabine for Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Study of the Combination of Pemetrexed and Irinotecan Every Two Weeks in Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE2